<?xml version="1.0" encoding="UTF-8"?>
<ArticalData xmlns="http://www.consortiumpublisher.com">
  <Header>
    <ArticleTitle>THE EFFECTIVENESS OF ASPIRIN WITH REGARD TO THE AGE OF THE PERSONS SUFFERING FROM CORONARY HEART DI</ArticleTitle>
  </Header>
  <ArticleParameters>
    <ArticleReceivingDate>2012-12-05</ArticleReceivingDate>
    <ArticleRevisedDate>2012-12-15</ArticleRevisedDate>
    <ArticleAcceptanceDate>2012-12-20</ArticleAcceptanceDate>
    <ArticlePublishedOn>9/30/2024 12:20:33 PM</ArticlePublishedOn>
    <Journal>Canadian Journal of Applied Sciences</Journal>
    <Volume>2</Volume>
    <Year>2012</Year>
    <ArticleType>Original research article</ArticleType>
    <FirstPage>134</FirstPage>
    <LastPage>139</LastPage>
    <CollectionYear>2012</CollectionYear>
    <ArticleDoi>http://dx.doi.org/10.21065/1925-7430.2.134</ArticleDoi>
    <Language>English</Language>
  </ArticleParameters>
  <Authors>
    <ArticleAuthors>Ayed Mizher Habeeb Al-Shammari1 *, Ian Naylor2 , Robert Naylor2</ArticleAuthors>
  </Authors>
  <keywords>
    <Articlekeywords>Systolic blood pressure, hypertension, coronary heart disease, aspirin</Articlekeywords>
  </keywords>
  <Abstract>
    <ArticleAbstract>The present invention is related to the effectiveness of aspirin with age of person suffering from
coronary heart disease. One of major cause which was observed in selected groups of patients
was smoking. The age group distribution with persons who were selected for aspirin treatment
who were actually has coronary heart diseases. A good comparison was established between
aspirin treatment and before aspirin treatment in all five groups of patients which were divided
on basis of their ages. The risk factor which is associated with such kind of treatment was also
considered. Over all it has been proved that aspirin has been effective for the majority of the age
groups studied, all of whom had at the beginning of the study, coronary heart disease. Clearly,
aspirin benefited 110 patients in the trial. For the remaining 40, in the age group 65-69 the results
were not favorable for the use of aspirin</ArticleAbstract>
  </Abstract>
</ArticalData>